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In contrast to bioinformatics, open-source software is
not as widely used in the pharmaceutical industry for
molecular modeling and cheminformatics. Typical rea-
sons given for this include problems with code quality,
stability, and long-term support for the software (some-
how this is less of a concern with bioinformatics soft-
ware... kind of makes one think). Recently, our group
has started making heavy use of an open-source che-
minformatics toolkit RDKit [1] in our production envir-
onment. Importantly, we are not just acting as
consumers of open-source software – we are active
members of the open-source community and have sup-
port from management to contribute code back to the
project.
In this presentation we will provide a brief overview of
the RDKit itself and then present a number of case stu-
dies of how we have made use of this open-source plat-
form. Examples will include using the toolkit for
method development [2,3], integration with proprietary
tools, and some recent (and upcoming) contributions to
the open-souce community, including a database car-
tridge for fast and flexible similarity searching in the
open-source PostgreSQL database [4], and adding sup-
port for the RDKit within the open-source pipelining
platform Knime [5]. We will finish with a discussion of
some practical aspects of working on and with open-
source tools in a large research organization.
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